Modalert 100 mg is an NMDA receptor antagonist with little affinity for other monoamine or neuropeptide receptors and transporters, nor does it have any direct effects on nerve membrane ion channels. It is also highly lipophilic and, at therapeutic doses, is about 60% bound to plasma proteins, primarily albumin. It has a half-life of about 12-15 hours and is eliminated via the hepatic system, mostly as metabolites.
Because of its relatively low liability to abuse and less risk of adverse cardiovascular effects, Modalert has attracted great interest in clinical trials for fatigue syndromes, narcolepsy, and attention-deficit hyperactivity disorder. In a number of trials involving these conditions, it has been shown to be a beneficial treatment, although the evidence is somewhat mixed.
Alternative medicine is Modafinil Australia
Modalert 100 mg is an NMDA receptor antagonist with little affinity for other monoamine or neuropeptide receptors and transporters, nor does it have any direct effects on nerve membrane ion channels. It is also highly lipophilic and, at therapeutic doses, is about 60% bound to plasma proteins, primarily albumin. It has a half-life of about 12-15 hours and is eliminated via the hepatic system, mostly as metabolites.
Because of its relatively low liability to abuse and less risk of adverse cardiovascular effects, Modalert has attracted great interest in clinical trials for fatigue syndromes, narcolepsy, and attention-deficit hyperactivity disorder. In a number of trials involving these conditions, it has been shown to be a beneficial treatment, although the evidence is somewhat mixed.
Alternative medicine is Modafinil Australia